Session Type
Meeting
Search Results for LOS
Plenary Presentations
Abstract Number: Plenary
SHM Converge 2021
Background: Antibiotics targeted against C. difficile bacteria are necessary, but insufficient, to achieve a durable clinical response because they have no effect on C. difficile spores that germinate within a disrupted microbiome. ECOSPOR-III evaluated SER-109, an investigational, biologically-derived microbiome therapeutic of purified Firmicute spores for treatment of recurrent CDI. Methods: Adults ≥18 years with recurrent […]
Oral Presentations
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Community acquired severity scores are well known and used routinely in predicting mortality and risk of inpatient and ICU admission in suspected bacterial pneumonia patients. However such scores have not been studied in patients with influenza infection and influenza pneumonia. We attempted to validate one such score, CURB65 and and identify other scores that […]
Oral Presentations
Abstract Number: OP2
SHM Converge 2022
Background: Clostridioides difficile infection (CDI) is a common, often nosocomial infection associated with substantial morbidity and mortality. Antibiotics are the most important modifiable risk factor, but empiric antibiotics remain appropriate for many patients with severe acute illness. Which antibiotics minimize the risk of CDI remains an important unanswered question. Because protective equipment and isolation were […]
Oral Presentations
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Community acquired severity scores are well known and used routinely in predicting mortality and risk of inpatient and ICU admission in suspected bacterial pneumonia patients. However such scores have not been studied in patients with influenza infection and influenza pneumonia. We attempted to validate one such score, CURB65 and and identify other scores that […]
Abstract Number: 9
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Hospital Onset Clostridium difficile infection (HOCDI) is one of the most common causes of hospital acquired diarrhea. As per a recent study, the mean healthcare costs attributable to primary Clostridium difficile infection (CDI) is about $24,205 per patient. This would be a lot more if the patients were to be discharged to skilled nursing […]
Abstract Number: 12
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Stony Brook University Hospital (SBUH) identified an opportunity to develop and implement prevention strategies to reduce hospital onset C. difficile infections (CDI). Hospital Onset (HO) CDI are included in National Healthcare Safety Network (NHSN) reporting and included with other hospital-acquired infections as publically reported data. CDI contribute to prolonged hospital stays, inappropriate antimicrobial use, […]
Abstract Number: 21
Hospital Medicine 2020, Virtual Competition
Background: Our institution’s rate of hospital acquired Clostridioides difficile (C. diff) infection (CDI) is higher than expected based on documented severity of illness of our patients. The C. diff testing algorithm at our institution utilizes a multi-step approach. It begins with two tests (antigen EIA and toxin A/B EIA). If the results of these two […]
Abstract Number: 28
SHM Converge 2023
Case Presentation: A 15-year-old male with HIV and inconsistent antiretroviral therapy adherence presented to an HIV clinic in Lilongwe, Malawi with weight loss, night sweats, lower extremity rash, and diarrhea. The rash on his legs had been present for 4 months and then spread to his arms. On exam, his vital signs were unremarkable. He […]
Abstract Number: 38
SHM Converge 2021
Background: For 6 months in 2018, a major quaternary-care teaching hospital underwent closure of operating rooms (OR) and cardiac catheterization laboratory (CCL) due to flooding/sterilization issues and planned upgrades. Surgery and interventional cardiology trainees were reassigned to other teaching hospital sites of Yale School of Medicine, with the anticipated impact on Medicine/subspecialties not fully known. […]
Abstract Number: 49
Hospital Medicine 2020, Virtual Competition
Background: When left untreated tuberculosis has the potential to cause significant morbidity and mortality. In many instances adequate microbiologic therapy does not exclude chronic respiratory complications. Bronchostenosis is an under recognized complication with potentially far reaching complications. Methods: Patients with evidence of bronchial stenosis and lung volume loss who were previously treated with pulmonary tuberculosis […]